Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis

Jodi R. Alt, Timothy Charles Greiner, John L. Cleveland, Christine M. Eischen

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

Mdm2 harnesses the p53 tumor suppressor, yet loss of one Mdm2 allele in Mdm2+/- mice has heretofore not been shown to impair tumor development. Here we report that Mdm2 haplo-insufficiency profoundly suppresses lymphomagenesis in Eμ-myc transgenic mice. Mdm2+/-Eμ-myc transgenics had greatly protracted rates of B cell lymphoma development with life spans twice that of wild-type transgenic littermates. Impaired lymphoma development was associated with drastic reductions in peripheral B cell numbers in Mdm2+/-Eμ-myc transgenics, and primary pre-B cells from Mdm2+/-Eμ-myc transgenics and Mdm2+/- littermates were extremely susceptible to spontaneous apoptosis. Loss of p53 rescued all of the effects of Mdm2 haplo-insufficiency, indicating they were p53 dependent. Furthermore, half of the lymphomas that ultimately emerged in Mdm2+/-Eμ-myc transgenics harbored inactivating mutations in p53, and the majority overcame haplo-insufficiency by overexpressing Mdm2. These results support the concept that Mdm2 functions are rate limiting in lymphomagenesis and that targeting Mdm2 will enhance p53-mediated apoptosis, compromising tumor development and/or maintenance.

Original languageEnglish (US)
Pages (from-to)1442-1450
Number of pages9
JournalEMBO Journal
Volume22
Issue number6
DOIs
StatePublished - Mar 17 2003

Fingerprint

Tumors
Cells
Lymphoma
Apoptosis
Neoplasms
B-Lymphoid Precursor Cells
B-Cell Lymphoma
Transgenic Mice
B-Lymphocytes
Cell Count
Alleles
Maintenance
Mutation

Keywords

  • Apoptosis
  • Lymphoma
  • Mdm2
  • Myc
  • P53

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis. / Alt, Jodi R.; Greiner, Timothy Charles; Cleveland, John L.; Eischen, Christine M.

In: EMBO Journal, Vol. 22, No. 6, 17.03.2003, p. 1442-1450.

Research output: Contribution to journalArticle

Alt, Jodi R. ; Greiner, Timothy Charles ; Cleveland, John L. ; Eischen, Christine M. / Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis. In: EMBO Journal. 2003 ; Vol. 22, No. 6. pp. 1442-1450.
@article{f9f08cdb705d46dcb71d6e2c06473217,
title = "Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis",
abstract = "Mdm2 harnesses the p53 tumor suppressor, yet loss of one Mdm2 allele in Mdm2+/- mice has heretofore not been shown to impair tumor development. Here we report that Mdm2 haplo-insufficiency profoundly suppresses lymphomagenesis in Eμ-myc transgenic mice. Mdm2+/-Eμ-myc transgenics had greatly protracted rates of B cell lymphoma development with life spans twice that of wild-type transgenic littermates. Impaired lymphoma development was associated with drastic reductions in peripheral B cell numbers in Mdm2+/-Eμ-myc transgenics, and primary pre-B cells from Mdm2+/-Eμ-myc transgenics and Mdm2+/- littermates were extremely susceptible to spontaneous apoptosis. Loss of p53 rescued all of the effects of Mdm2 haplo-insufficiency, indicating they were p53 dependent. Furthermore, half of the lymphomas that ultimately emerged in Mdm2+/-Eμ-myc transgenics harbored inactivating mutations in p53, and the majority overcame haplo-insufficiency by overexpressing Mdm2. These results support the concept that Mdm2 functions are rate limiting in lymphomagenesis and that targeting Mdm2 will enhance p53-mediated apoptosis, compromising tumor development and/or maintenance.",
keywords = "Apoptosis, Lymphoma, Mdm2, Myc, P53",
author = "Alt, {Jodi R.} and Greiner, {Timothy Charles} and Cleveland, {John L.} and Eischen, {Christine M.}",
year = "2003",
month = "3",
day = "17",
doi = "10.1093/emboj/cdg133",
language = "English (US)",
volume = "22",
pages = "1442--1450",
journal = "EMBO Journal",
issn = "0261-4189",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis

AU - Alt, Jodi R.

AU - Greiner, Timothy Charles

AU - Cleveland, John L.

AU - Eischen, Christine M.

PY - 2003/3/17

Y1 - 2003/3/17

N2 - Mdm2 harnesses the p53 tumor suppressor, yet loss of one Mdm2 allele in Mdm2+/- mice has heretofore not been shown to impair tumor development. Here we report that Mdm2 haplo-insufficiency profoundly suppresses lymphomagenesis in Eμ-myc transgenic mice. Mdm2+/-Eμ-myc transgenics had greatly protracted rates of B cell lymphoma development with life spans twice that of wild-type transgenic littermates. Impaired lymphoma development was associated with drastic reductions in peripheral B cell numbers in Mdm2+/-Eμ-myc transgenics, and primary pre-B cells from Mdm2+/-Eμ-myc transgenics and Mdm2+/- littermates were extremely susceptible to spontaneous apoptosis. Loss of p53 rescued all of the effects of Mdm2 haplo-insufficiency, indicating they were p53 dependent. Furthermore, half of the lymphomas that ultimately emerged in Mdm2+/-Eμ-myc transgenics harbored inactivating mutations in p53, and the majority overcame haplo-insufficiency by overexpressing Mdm2. These results support the concept that Mdm2 functions are rate limiting in lymphomagenesis and that targeting Mdm2 will enhance p53-mediated apoptosis, compromising tumor development and/or maintenance.

AB - Mdm2 harnesses the p53 tumor suppressor, yet loss of one Mdm2 allele in Mdm2+/- mice has heretofore not been shown to impair tumor development. Here we report that Mdm2 haplo-insufficiency profoundly suppresses lymphomagenesis in Eμ-myc transgenic mice. Mdm2+/-Eμ-myc transgenics had greatly protracted rates of B cell lymphoma development with life spans twice that of wild-type transgenic littermates. Impaired lymphoma development was associated with drastic reductions in peripheral B cell numbers in Mdm2+/-Eμ-myc transgenics, and primary pre-B cells from Mdm2+/-Eμ-myc transgenics and Mdm2+/- littermates were extremely susceptible to spontaneous apoptosis. Loss of p53 rescued all of the effects of Mdm2 haplo-insufficiency, indicating they were p53 dependent. Furthermore, half of the lymphomas that ultimately emerged in Mdm2+/-Eμ-myc transgenics harbored inactivating mutations in p53, and the majority overcame haplo-insufficiency by overexpressing Mdm2. These results support the concept that Mdm2 functions are rate limiting in lymphomagenesis and that targeting Mdm2 will enhance p53-mediated apoptosis, compromising tumor development and/or maintenance.

KW - Apoptosis

KW - Lymphoma

KW - Mdm2

KW - Myc

KW - P53

UR - http://www.scopus.com/inward/record.url?scp=0345268720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345268720&partnerID=8YFLogxK

U2 - 10.1093/emboj/cdg133

DO - 10.1093/emboj/cdg133

M3 - Article

VL - 22

SP - 1442

EP - 1450

JO - EMBO Journal

JF - EMBO Journal

SN - 0261-4189

IS - 6

ER -